This move is archived. Current quotes and coverage live on the stock page.
Follow AVCR
Avricore Health Inc faces a significant drop in market value as investors react to recent developments.
Avricore Health Inc (AVCR.V) is experiencing a sharp decline in stock value, down 11.11% to CA$0.08 in today's trading session. This downturn raises questions about the company's future prospects and investor confidence.
Advertisement
Avricore Health Inc
AVCR.V
AVCR.V
Avricore Health Inc
WealthAwesomeMarket cap
$6.95M
52W high
$0.10
52W low
$0.04
1W change
-15.38%
Beta
0.36
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on AVCR's historical volatility
30-Day Vol
205.9%
Annualized
90-Day Vol
155.1%
Annualized
Trend (90d)
+0.0%
Annualized drift
90d Mean
C$0.06
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.06 | C$0.03 – C$0.11 |
| 60 trading days | C$0.06 | C$0.02 – C$0.15 |
| 90 trading days | C$0.06 | C$0.02 – C$0.19 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors should closely monitor Avricore's strategic moves and market conditions, especially in light of recent stock option grants and partnerships.
Avricore Health Inc Market Cap Drops Below CA$8.2 Million
With a current market cap of CA$8,214,028, Avricore is facing increasing pressure as its stock value diminishes.
Bull case
If Avricore can effectively use its partnership with Abbott to grow its HealthTab™ platform, it could boost revenue and help regain investor confidence.
Bear case
Ongoing market skepticism and operational challenges might hinder Avricore's growth, potentially leading to further declines in stock value.
Market Reaction to Stock Options Grant
Advertisement
Avricore's recent announcement of granting stock options for 3,300,000 common shares at an exercise price of CA$0.06 may have contributed to investor unease. While stock options can help align interests between management and shareholders, they can also dilute existing shares, raising concerns about the company's commitment to shareholder value.
Partnership with Abbott: A Double-Edged Sword
The collaboration with Abbott to distribute point-of-care testing products through the HealthTab™ platform is a significant step for Avricore. However, investors may be cautious about the risks involved in scaling this partnership, especially in a competitive healthcare market. If the partnership doesn't meet expectations, it could negatively affect Avricore's stock performance.
Future Outlook for Avricore Health Inc
As Avricore navigates these challenges, investors should keep an eye on its strategic decisions and market conditions. The company's ability to leverage its technological advancements and partnerships will be crucial for its stock recovery.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
